Inspire Medical Systems, Inc. (INSP)
NYSE: INSP · Real-Time Price · USD
53.72
-0.96 (-1.76%)
Mar 20, 2026, 4:00 PM EDT - Market closed

Inspire Medical Systems Income Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
911.98802.8624.8407.86233.39
Revenue Growth (YoY)
13.60%28.49%53.19%74.75%102.28%
Cost of Revenue
133.23122.9996.5866.1233.28
Gross Profit
778.76679.82528.22341.74200.12
Selling, General & Admin
624.64529.61451.96320.69202.62
Research & Development
103.17114.13116.5468.6537.35
Total Operating Expenses
727.8643.74568.49389.33239.97
Operating Income
50.9536.08-40.27-47.59-39.85
Interest Income
17.5423.2520.565.050.13
Interest Expense
-0.14-0.02--1.68-2.13
Other Non-Operating Income (Expense)
2.660.860.20.050.12
Total Non-Operating Income (Expense)
20.0624.0820.763.42-1.89
Pretax Income
65.758.45-19.91-44.27-41.97
Provision for Income Taxes
-79.734.941.250.610.07
Net Income
145.4253.51-21.15-44.88-42.04
Net Income to Common
145.4253.51-21.15-44.88-42.04
Net Income Growth
171.77%----
Shares Outstanding (Basic)
2930292827
Shares Outstanding (Diluted)
3031292827
Shares Change (YoY)
-2.57%4.24%4.38%2.97%4.56%
EPS (Basic)
4.951.80-0.72-1.60-1.54
EPS (Diluted)
4.891.75-0.72-1.60-1.54
EPS Growth
179.43%----
Free Cash Flow
78.4891.121.022.47-24.79
Free Cash Flow Growth
-13.88%8798.73%-58.59%--
Free Cash Flow Per Share
2.642.980.030.09-0.91
Gross Margin
85.39%84.68%84.54%83.79%85.74%
Operating Margin
5.59%4.49%-6.45%-11.67%-17.07%
Profit Margin
15.95%6.67%-3.39%-11.00%-18.01%
FCF Margin
8.61%11.35%0.16%0.61%-10.62%
EBITDA
64.9142.63-37.43-45.73-38.63
EBITDA Margin
7.12%5.31%-5.99%-11.21%-16.55%
EBIT
50.9536.08-40.27-47.59-39.85
EBIT Margin
5.59%4.49%-6.45%-11.67%-17.07%
Effective Tax Rate
-121.35%8.46%-6.26%-1.38%-0.17%
Updated Dec 31, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q